Skip to content

Commercialization



The lead commercializing partner and managing party for products resulting from this project is DVS Sciences Inc.

For ordering information, please click here.

CyTOF™

CyTOF™

Instrumentation for massively multiplexed analysis of individual cells or beads.

MAXPAR™

MAXPAR™

Reagents for multiplexed bioassays of bulk or discrete samples.

This project is funded by Genome Canada through the Ontario Genomics Institute:

Genome Canada Ontario Genomics Institute - The Future is in Our Genes.

Complementary funding is gratefully acknowledged from:

DVS Sciences - BioAnalytical Innovation - www.dvssciences.com
DVS Sciences

 

Ministry of Research and Innovation - www.mri.gov.on.ca/english/default.asp
Ministry of Research and Innovation

News & Events

Raising the Bar: The Royal Society of Chemistry has published an interview with Scott Tanner.

 

Click here to find out about upcoming and past events.

 

Publications

  • Bendall, S.C, et al. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum.
    Science 6 May 2011: pp. 687-696.
  • Abdelrahman, A.I. et al. Metal-containing polystyrene beads as standards for mass cytometry. Journal of Analytical Atomic Spectrometry 25 (3):260-268, 2010.
  • Thickett, S. C., et al. Bio-functional, lanthanidelabeled polymer particles by seeded emulsion polymerization and their characterization by novel ICP-MS detection. Journal of Analytical Atomic Spectrometry 25 (3):269-281, 2010.

 

Click here for more publications.